Syn-Med-Chemist-"Quintessential Synthetic Chemistry"---A Synthetic Chemist's Perception......
Saturday, December 5, 2015
FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma
FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment